Down-regulation of circular RNA ITCH and circHIPK3 in gastric cancer tissues

Down-regulation of circular RNA ITCH and circHIPK3 in gastric cancer tissues

Background/aim: Gastric cancer (GC) is one of the major causes of cancer mortality worldwide. As a novel type of endogenousnoncoding RNAs, circular RNAs (circRNAs) are formed by a covalent link between 5’ and 3’ ends. They are very stable and abundantin eukaryotes. As there were no reported studies on the expression profiles of circular RNA ITCH (cir-ITCH) and circHIPK3 in GC, inthe current study, we aimed to delineate the expression profiles and clinicopathological relevance of these two circRNAs in GC tissuescompared to their paired adjacent noncancerous tissues.Materials and methods: Quantitative real-time polymerase chain reaction was performed to evaluate cir_ITCH and circHIPK3expression in 30 paired gastric cancer tissues. The clinicopathological relevance of these two circular RNAs’ expression levels withgastric cancer was further examined.Results: Our results showed that the expression of cir_ITCH and circHIPK3 were significantly downregulated in GC tumoral tissuescompared with their paired adjacent nonneoplastic counterparts. Further analyses showed that cir_ITCH and circHIPK3 expressionlevels were related with numerous clinicopathological features of tumoral tissues.Conclusion: Cir_ITCH and circHIPK3 may have imperative roles in GC and serve in the future as potential prognostic biomarkers in GC.

___

  • 1. Keeney S, Bauer TL. Epidemiology of adenocarcinoma of the esophagogastric junction. Surg Oncol Clin N Am 2006; 15: 687-696.
  • 2. Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med 2009; 12: 576-583.
  • 3. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol 2009; 20: 556-563.
  • 4. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H. Five common cancers in Iran. Arch Iran Med 2010; 13: 143-146.
  • 5. Riquelme I, Saavedra K, Espinoza JA, Weber H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC, Bizama C. Molecular classification of gastric cancer: towards a pathway-driven targeted therapy. Oncotarget 2015; 6: 24750-24779.
  • 6. Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol 2015; 12: 381-388.
  • 7. Qu S, Yang X, Li X, Wang J, Gao Y, Shang R, Sun W, Dou K, Li H. Circular RNA: a new star of noncoding RNAs. Cancer Lett 2015; 365: 141-148.
  • 8. Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. P Natl Acad Sci USA 1976; 73: 3852-3856.
  • 9. Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, Chen D, Gu J, He X, Huang S. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 2015; 25: 981.
  • 10. Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013; 495: 333-338.
  • 11. Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. Celltype specific features of circular RNA expression. PLoS Genet 2013; 9: e1003777.
  • 12. Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z, Sharpless NE. Expression of linear and novel circular forms of an INK4/ARFassociated non-coding RNA correlates with atherosclerosis risk. PLoS Genet 2010; 6: e1001233.
  • 13. Lukiw WJ. Circular RNA (circRNA) in Alzheimer’s disease (AD). Front Genet 2013; 4: 307.
  • 14. He J, Xie Q, Xu H, Li J, Li Y. Circular RNAs and cancer. Cancer Lett 2017; 396: 138-144.
  • 15. Wan L, Zhang L, Fan K, Cheng ZX, Sun QC, Wang JJ. Circular RNA-ITCH Suppresses lung cancer proliferation via inhibiting the Wnt/beta-catenin pathway. Biomed Res Int 2016; 2016: 1579490.
  • 16. Li F, Zhang L, Li W, Deng J, Zheng J, An M, Lu J, Zhou Y. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/beta-catenin pathway. Oncotarget 2015;6:6001-13.
  • 17. Huang G, Zhu H, Shi Y, Wu W, Cai H, Chen X. cir-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/βcatenin pathway. PloS one 2015; 10: e0131225.
  • 18. Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B, Luo Y, Lyu D, Li Y, Shi G et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun 2016; 7: 11215.
  • 19. Bahari F, Emadi-Baygi M, Nikpour P. miR-17-92 host gene, uderexpressed in gastric cancer and its expression was negatively correlated with the metastasis. Indian J Cancer 2015; 52: 22-25.
  • 20. Emadi-Baygi M, Nikpour P, Emadi-Andani E. SIX1 overexpression in diffuse-type and grade III gastric tumors: features that are associated with poor prognosis. Adv Biomed Res 2015; 4: 139.
  • 21. Baratieh Z, Khalaj Z, Honardoost MA, Emadi-Baygi M, Khanahmad H, Salehi M, Nikpour P. Aberrant expression of PlncRNA-1 and TUG1: potential biomarkers for gastric cancer diagnosis and clinically monitoring cancer progression. Biomark Med 2017; 11: 1077-1090.
  • 22. Washington K. 7th Edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010; 17: 3077-3079.
  • 23. Baygi ME, Soheili ZS, Schmitz I, Sameie S, Schulz WA. Snail regulates cell survival and inhibits cellular senescence in human metastatic prostate cancer cell lines. Cell Biol Toxicol 2010; 26: 553-567.
  • 24. Li Y, Zheng F, Xiao X, Xie F, Tao D, Huang C, Liu D, Wang M, Wang L, Zeng F et al. CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep 2017; 18: 1646-1659.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Emre YALÇIN, Şehmus PALA, Remzi ATILGAN, Tuncay KULOĞLU, Ebru ÖNALAN, Gökhan ARTAŞ, İlay BURAN

Long-term monitoring of Graves’ disease in children and adolescents: a single-center experience

Behzat ÖZKAN, Ceyhun DİZDARER, Özlem NALBANTOĞLU, Özge KÖPRÜLÜ, Korcan DEMİR, Selma TUNÇ, Hatice ORTAÇ

Urinary phytate concentration and risk of fracture determined by the FRAX index in a group of postmenopausal women

BARTOLOME MARÍ, ANGEL A. LOPEZ-GONZALEZ, FELIX GRASES, MATIAS TOMÁS-SALVÁ, ADRIAN RODRIGUEZ

Ayşegül CEYLAN, İbrahim ASIK

Kübra Esen SALMAN, İlknur ALTUNAY, Andaç SALMAN

The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases

İbrahim Celalettin HAZNEDAROĞLU, Salih AKSU, Nilgün SAYINALP, Seyhan TÜRK, Osama JAVAD, Can TÜRK, Elif Sena TEMİRCİ, Müfide OKAY

Mild to moderate proteinuria is a heralding sign for acute kidney injury and mortality for intensive care unit patients

Mustafa ARICI, Arzu TOPELİ, Tolga YILDIRIM, Abdullah ASLAN, Tural PAŞAYEV, Ömer AKÇAYIR, Sıla ÇETİK, Damla EYÜPOĞLU, Hasan H. YETER

Derya Hopanci BIÇAKLI, Rüksan ÇEHRELİ, Ahmet ÖZVEREN, Reci MESERİ, Rüçhan USLU, Mehmet UYAR, Bülent KARABULUT, Selahattin Fehmi AKÇİÇEK

Rumeysa Olcay BAYRAM, Hülya ÖZDEMİR, Ayça EMSEN, Hatice Türk DAĞI, Hasibe ARTAÇ

Results of home-based modified combined decongestive therapy in patients with lower extremity lymphedema

Meltem RAMOĞLU, Ethem GÜNEREN, Alis KOSTANOĞLU